Research indicates it can increase collagen production by up to 70% in laboratory studies
Nonetheless, to date the only FDA- and EMA-approved NRF2 activator for the treatment of relapsing-remitting MS and psoriasis is DMF, and its therapeutic potential in ALS patients in terms of efficacy, safety and tolerability, is now being evaluated in a phase-II clinical trial [313]
Overall, the inherent anti-oxidative ability of GHK promotes wound healing by reducing inflammatory response, and this ability is further enhanced by the introduction of cell surface-reactive cell-targeting peptide
[PMID: 7984034] PubMed record related to this compound for laboratory literature review
Since we observed an activation of NRF2 upon GSH depletion, we expected NRF2 to be essential for preventing liver damage
The GHK-Cu half life in plasma is roughly 30 minutes